Cerulean Announces Results from Phase 2b Cancer Trial
CRLX101 is being studied in clinical trials in renal cell carcinoma in combination with Avastin®03/23/2013
Source: Kidney Cancer Association - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology